For licensed healthcare professionals. The protocol figures below are drawn from published labeling and peer-reviewed literature for educational reference. They are not a prescription, not a recommendation, and not a substitute for the dispensing pharmacy's labeling or your own clinical judgment.
Healing & Recovery
ARA-290
aka Cibinetide
Investigational Not WADA-listed
Erythropoietin-derived 11-mer that targets the innate repair receptor. Studied for neuropathic pain in sarcoidosis and diabetic neuropathy.
At a glance
- Common vial size
- 14 mg
- Reference dose
- 4 mg
- Frequency
- Daily × 28 days, cycled
Reference titration protocol
4 mg daily during a 28-day cycle.
| Step | Dose | Duration | Administrations / week |
|---|---|---|---|
| 1 | 4 mg | 4 weeks | 7× |
Reconstitution example
A 14 mg vial reconstituted with 2 mL of bacteriostatic water yields 7 mg/mL. Confirm the diluent and volume against the labeling that ships with the vial.
Open this configuration in the calculatorAvailable formulations
Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.
- 0 · Lyophilized PowderR&D
- Injectable503A
- Lyophilized PowderR&D
References
Pricing and ordering are for verified accounts
VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.
Also in Healing & Recovery
BPC-157
Pentadecapeptide derived from a gastric protein. Promoted for tendon/ligament repair and GI healing. No FDA approval; FDA placed on Category 2 compounding list.
TB-500
Synthetic fragment of thymosin β-4. Promoted for tissue repair and inflammation. WADA-prohibited in sport.
GHK-Cu
Copper-binding tripeptide implicated in wound healing, hair follicle stimulation, and skin remodeling. Used topically and via injection.